Revenue Agenda
  • Investing
  • Latest News
  • Editor’s Pick
  • Economy
  • Investing
  • Latest News
  • Editor’s Pick
  • Economy
No Result
View All Result
Revenue Agenda
No Result
View All Result
Home Editor's Pick

Macy’s is closing 150 stores nationwide as it seeks ‘bold new chapter’ with greater focus on luxury

by
February 28, 2024
in Editor's Pick
0
Macy’s is closing 150 stores nationwide as it seeks ‘bold new chapter’ with greater focus on luxury
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Macy’s plans to close approximately 150 stores nationwide as part of a massive reorganization that will see it pivot to a greater focus on luxury sales.

The retailer on Tuesday announced an initiative it’s calling a ‘bold new chapter’ that will involve shuttering ‘underproductive’ locations, including approximately 50 by the end of the company’s current fiscal year.

In an email, a Macy’s spokesperson declined to comment about which specific stores are closing. In a statement obtained by NBC on Tuesday, San Francisco Mayor London Breed said she had learned that Macy’s 400,000 square-foot flagship location in the city’s Union Square will eventually be part of the closures, though not in the initial round of 50.

The closures will leave approximately 350 Macy’s locations, as well as Bloomingdale’s and Bluemercury beauty and skincare stores.

The company sees those latter brands as its future: It said it plans to take advantage of its leadership position in the luxury market, where it said Bloomingdale’s and Bluemercury have been ‘outperformers’ within the Macy’s portfolio.

The company plans to build out 15 new Bloomingdale’s stores and at least 30 new Bluemercury stores, along with roughly 30 Bluemercury remodels, over the next three years.

“We are making the necessary moves to reinvigorate relationships with our customers through improved shopping experiences, relevant assortments and compelling value,” CEO Tony Spring said in a news release.

Macy’s has been under pressure from investor activists seeking an outright sale of the company due to its decadelong underperformance, with Macy’s real estate considered its most valuable asset.

However, Macy’s recently rejected a takeover offer, saying it undervalued the firm.

Wall Street’s immediate reaction to Tuesday’s announcement was negative, with shares trading more than 2% lower in premarket action.

This post appeared first on NBC NEWS
Previous Post

House Republicans subpoena DOJ for materials related to Special Counsel Hur interview of Joe Biden

Next Post

Man pleads guilty to threatening Michigan official over 2020 election

Next Post
Man pleads guilty to threatening Michigan official over 2020 election

Man pleads guilty to threatening Michigan official over 2020 election

  • Trending
  • Comments
  • Latest
Bitcoin Slips to $83.6K Amid Nvidia’s $5.5B Charge

Bitcoin Slips to $83.6K Amid Nvidia’s $5.5B Charge

October 7, 2025
Uranium Price Update: Q3 2025 in Review

Uranium Price Update: Q3 2025 in Review

October 16, 2025
Top 10 Potash Countries by Production (Updated 2024)

Top 10 Potash Countries by Production (Updated 2024)

August 21, 2024
Top 10 Phosphate Countries by Production (Updated 2024)

Top 10 Phosphate Countries by Production (Updated 2024)

August 1, 2024
Mark Skousen: Gold, Silver in Major Bull Market, “Permanent Inflation” is Here

Mark Skousen: Gold, Silver in Major Bull Market, “Permanent Inflation” is Here

0
New Hampshire Gov. Sununu signs $15.2B ‘miracle’ budget into law

New Hampshire Gov. Sununu signs $15.2B ‘miracle’ budget into law

0

Pennsylvania House clears tax credits for new teachers, nurses, police officers

0
Evers signs bipartisan sales tax bill aimed at sparing Milwaukee from bankruptcy

Evers signs bipartisan sales tax bill aimed at sparing Milwaukee from bankruptcy

0
Mark Skousen: Gold, Silver in Major Bull Market, “Permanent Inflation” is Here

Mark Skousen: Gold, Silver in Major Bull Market, “Permanent Inflation” is Here

November 11, 2025
InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue and Clear Path to Value

InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue and Clear Path to Value

November 11, 2025
Questcorp Mining Receives Initial Investment from U.K. Based Institutional Investor Sorbie Bornholm LP.

Questcorp Mining Receives Initial Investment from U.K. Based Institutional Investor Sorbie Bornholm LP.

November 11, 2025
1911 Gold Intersects up to 24.83 g/t Gold over 2.60 m on San Antonio West at the True North Gold Project

1911 Gold Intersects up to 24.83 g/t Gold over 2.60 m on San Antonio West at the True North Gold Project

November 11, 2025
Enter Your Information Below To Receive Trading Ideas and Latest News

Error: Contact form not found.

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Recent News

Mark Skousen: Gold, Silver in Major Bull Market, “Permanent Inflation” is Here

Mark Skousen: Gold, Silver in Major Bull Market, “Permanent Inflation” is Here

November 11, 2025
InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue and Clear Path to Value

InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue and Clear Path to Value

November 11, 2025
Questcorp Mining Receives Initial Investment from U.K. Based Institutional Investor Sorbie Bornholm LP.

Questcorp Mining Receives Initial Investment from U.K. Based Institutional Investor Sorbie Bornholm LP.

November 11, 2025
1911 Gold Intersects up to 24.83 g/t Gold over 2.60 m on San Antonio West at the True North Gold Project

1911 Gold Intersects up to 24.83 g/t Gold over 2.60 m on San Antonio West at the True North Gold Project

November 11, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 revenueagenda.com | All Rights Reserved

No Result
View All Result
  • Investing
  • Latest News
  • Editor’s Pick
  • Economy

Copyright © 2025 revenueagenda.com | All Rights Reserved